| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. | Chief Medical Officer | Common Stock | 103,417 | $191,321 | $1.85 | 10 Jan 2023 | Direct |
| Jounce Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 55,000 | 01 Feb 2022 | Direct | ||
| CONSTELLATION PHARMACEUTICALS INC | Director | Stock Options (Right to buy) | 0 | 15 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000164045523000011-trehu-elizabeth-2023-01-09 | Jounce Therapeutics, Inc. | 09 Jan 2023 | 2 | -$10,316 | 4 | Chief Medical Officer | 11 Jan 2023, 19:33 |
| /report/000164045522000016-trehu-elizabeth-2022-02-01 | Jounce Therapeutics, Inc. | 01 Feb 2022 | 2 | $0 | 4 | Chief Medical Officer | 03 Feb 2022, 18:36 |
| /report/000164045522000011-trehu-elizabeth-2022-01-07 | Jounce Therapeutics, Inc. | 07 Jan 2022 | 2 | -$57,700 | 4 | Chief Medical Officer | 11 Jan 2022, 19:57 |
| /report/000156218021004986-trehu-elizabeth-2021-07-15 | CONSTELLATION PHARMACEUTICALS INC | 15 Jul 2021 | 4 | $0 | 4 | Director | 19 Jul 2021, 17:40 |
| /report/000156218021004075-trehu-elizabeth-2021-06-02 | CONSTELLATION PHARMACEUTICALS INC | 02 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 17:45 |